COMBINATION OF AN OPIOID RECEPTOR AGONIST AND AN OPIOID RECEPTOR ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

摘要

The present invention relates to the use of a combination of oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical dosage form for treating patients with Parkinson's disease suffering from dyskinesia, wherein the dyskinesia is induced by a dopaminergic such as L-dopa (LID).